May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Pituitary Adenylate Cyclase–Activating Peptide (PACAP) Stimulates Proliferation and Production of Interleukin–6 in Cultured Rat Muller Cells
Author Affiliations & Notes
  • Y. Shinohara
    Bioengineering Institute, Assessment Research, Nidek Co., Ltd., Aichi, Japan
  • T. Seki
    Ophthalmology, Kozawa Eye Hospital Eye Research Center, Mito, Japan
    Anatomy and Ophthalmology, Showa University School of Medicine, Tokyo, Japan
  • C. Taki
    Bioengineering Institute, Assessment Research, Nidek Co., Ltd., Aichi, Japan
  • M. Nakatani
    Bioengineering Institute, Assessment Research, Nidek Co., Ltd., Aichi, Japan
  • M. Ozawa
    Bioengineering Institute, Assessment Research, Nidek Co., Ltd., Aichi, Japan
  • S. Nishimura
    Bioengineering Institute, Assessment Research, Nidek Co., Ltd., Aichi, Japan
  • A. Takaki
    Integrative Physiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  • S. Shioda
    Anatomy, Showa University School of Medicine, Tokyo, Japan
  • Footnotes
    Commercial Relationships  Y. Shinohara, None; T. Seki, None; C. Taki, None; M. Nakatani, None; M. Ozawa, None; S. Nishimura, None; A. Takaki, None; S. Shioda, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 181. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Shinohara, T. Seki, C. Taki, M. Nakatani, M. Ozawa, S. Nishimura, A. Takaki, S. Shioda; Pituitary Adenylate Cyclase–Activating Peptide (PACAP) Stimulates Proliferation and Production of Interleukin–6 in Cultured Rat Muller Cells . Invest. Ophthalmol. Vis. Sci. 2005;46(13):181.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Pituitary adenylate cyclase–activating peptide (PACAP) is known to prevent delayed neuronal cell death after an ischemic event in the hippocampus, partly thorough Interleukin 6 (IL–6) released from astrocytes. In order to elucidate neuroprotective effect of PACAP in the retina, we investigated (1) the mitogenic effects and (2) the changes of IL–6 production by PACAP in cultured rat Muller cells, which are dominant glial cells in the retina. Methods: Muller cells were isolated from 14– or 15–day–old Wistar rat, and cultured with DMEM with 10% fetal bovine serum at 37 degrees C in 5% CO2. After two passages, the cells were treated with different concentrations of PACAP 38 in serum–free medium for 48 hours. Cell proliferation was assayed by the incorporation of thymidine analog BrdU. IL–6 levels in the supernatants obtained from 24–hour cultures were determined by a bioassay using B9 cells, which is the IL–6 dependent murine hybridoma subclone cell. Results: Incorporation of BrdU was significantly stimulated by PACAP 38 at 10–9, 10–8 and 10–7 M. The maximum stimulation seen at 10–9M was 2.23–fold above the control. IL–6 production was enhanced by PACAP 38 from 10–12M to 10–6M. Compared with the IL–6 level of 0.40 +/– 0.33 pg/mL (mean +/– SD; n = 4) in the control medium, IL–6 levels in PACAP exposed media were 40–fold higher with the PACAP concentration as low as 10–12 M. Conclusions: These results demonstrate that Muller cells are target cells of PACAP in the retina, and may play a neuroprotective role thorough the release of IL–6 triggered by PACAP.

Keywords: Muller cells • neuropeptides • retinal culture 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×